Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Antimicrobials > Antimicrobials > Flashcards

Antimicrobials Flashcards

1
Q

Trimethoprim

A 
Bind AS  of dihydrofolate reductase
PO or IV 
Plasmid with alternative enzyme (dhfr gene)
Teratogen (not used in first trimester)
Rarely used alone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sulfonamide

A

Comp inhibitor of dihydropteroate synthetase
PO or IV
Chrom mut inc PABA/alter bidning or plasmid with alternative enz
Kernicterus in newborn, drug toxicities with warfarin and phenytoin
Rarely used alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Trimethoprim-Sulfamethoxazole

A

PO or IV
Very broad: GP, GN, protoza, fungi (pneumocystis jirovecci)
Lower potential for resistance
N/V, headache, rash; hyperfalemia, hep, pancreatitis; S-J, toxic epidermal necrolysis, aplastic/hemolytic anemia, thrombocytopenia
Penetrate tissues well (inc prostate CSF) and excellent bioavailability
UTI, RI, bacterial diarrhea (limited due to E coli res), skin/soft tissue infection (S aureus), MRSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Quinolones (ciproflixacin, levo, moxi)

A

Stabilize topo II or IV complex with DNA via ds breaks, interfere with txn/rep, cell dies
PO or IV
All GN, atypicals, mycobacteria; levo/moxi GP, moxi anaerobes
muts (1 or 2) in target enzymes and efflux pumps
N/V, headache, nervous/anx; seizures, C diff, prolong QT, tendon rupture, arthropathies
Excellent bioavailability and tissue penetration; absorption poor with divalent cations; long half life; all but moxi excreted in urine
GI infections; UTIs (cipro; not moxi bc don’t penetrate UT); pneumonia (levo/moxi); mycobacterial infection; polymicrobial infection from anaerobic activity (moxi)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Nitrofurantoin

A

Damage DNA and bind RNA (no tln)
PO
GP, GN uropathogens
Resistance develops with repeated use
Nausea; pulmonary fibrosis, acute pulmonary reactions
Doesn’t reach adequate serum levels but concentrated in urine
Only used for UTIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Rifamycin (rifampin, rifaximin)

A

Inhibit RNA pol (-static)
Rifampin (PO/IV) and Rifaximin (PO)
GP, GN, anaerobic, mycobacteria
Rapid/preexisiting resistance due to muts in target enzyme
Rifampin turn sec orange; N/V/D; thrombocytopenia, leukopenia, anemia; hepatitis
Rifaximin not abs; others good bioavailability and tissue penetration; metabolized by cp450 (rifampin inducer of p450)
Prophylaxis (N meningitides, S aurea); TB (with others); rifaximin only for GI infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Fidaxomicin

A 
Inhibit RNA pol opening of DNA
PO
Only GP 
Non-absorbable 
C diff treatment (less recurrence than in vanc)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Penicillin overview

A 
Beta-lactam: 4 member ring resemble terminal D-ala-D-ala of peptidoglycan so irreversibly bind/inhibit transpeptidase 
Intrinsic resistance to Mycoplsama (no cell wall; beta lactamases; modified PBP (PBP2A from mecA in MRSA); efflux pumps; dec porins/permeability
Hypersensitivity rxns (rash, serum sicknes, cytopenias, acute interstitial nephritis, hives, anaphylaxis); seizures at high conc
Bactericidal, high TI, good penetration (CSF), excreted thru kidneys, short half life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Penicillin G

A

IV or IM
GP cocci (strep, enterococci), GN cocci, GP anaerobes, spirochetes
Penicillinase
Short half life
Strep infections (A: strep throat and skin/soft tissue; B: pneumonia); syphilis; anaerobic infections (dental abscess, human bite)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Semi-synthetic penicillins: nafcillin, dicloxacillin

A

Naf: IV; dicloxa: PO
Only GP of PenG
Resistant to beta-lactamases (s aureus)
MSSA infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Aminopenicillins: ampicillin, amoxicillin

A 
Amp: IV, amoxi: PO 
PenG with improved GN (H flu, E coli)
Beta-lactamases 
GI distress; amoxi: maculopapular rash in patients with mononucleosis 
CA-HEENT/RI and CA-UTIs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Anti-pseudomonal: piperacillin, ticarcillin

A

IV
PenG with even better GN (pseudomonas)
Beta-lactamase limits use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Beta-lactamase inhibitors: amp-sulbactam, amoxi-clavulanic acid, pipercillin-taxobactam

A

Bind and hydrolyze beta-lactamase (suicide inhibitor)
Extend spectrum to include MSSA, and GN anaerobes (Pseudomonas)
Polymicrobial infections from anaerobes (skin/soft tissue in diabetics, intra-abdominal infections, odontogenic); empiric if causative agent unknown

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cephalosporin overview

A

Beta-lactam
GN spectrum inc with gen (except 5th)
Most have some GP (not enterococci)
Most don’t have anaerobic activity)
More resistant to beta-lactamases than penicillin (ESBLs); intrinsic resistance to pseudomonas, enterococci; alter memb permebaility; alter PBP (MRSA)
Well tolerated (hypersenstivity and cross reactivity with penicillin allergy)
Eliminated in urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

1st gen: cefazolin, cephalexin

A

Cef: IV; ceph: PO (only PO cephalsporin)
GN; GP but limited by resistance
excellent tissue penetration
Cef for prophylaxis during clean surgery; no longer for strep/staph skin and soft tissue infection due to CA-MRSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

2nd gen: cefoxitin

A

IV
inc GN AND anaerobic
Prophylaxis for intr-abd surgery; intra-abd infection

17
Q

3rd gen: ceftriaxone, ceftazidime

A

IV
inc GN; low GP activity; ceftazidime active against pseudomonas
Excellent tissue penetration (inc CNS)
CA-pneumonia, meningitis, serious infections (endocarditis, osteomyelitis); UTI in hospital

18
Q

4th gen: cefepime

A

IV
broad: GN (inc pseudomonas) and GP
serious/resistant infections bc highly resistant to beta-lacatamases (even ESBL)

19
Q

5th gen: ceftaroline

A

IV
similar to 3rd gen but include MRSA
Susceptible to ESBLs
used for MRSA

20
Q

Carbapenems: imipenem, doripenem, ertapenem

A

IV
GN (pseudomonas), GP (E faecalis), anaerobes (erta = not for pseudomonas and acinetobacter)
Typically resistant to beta-lactamases (some carbapenemase)
Hypersenstivity and cross reactivity with penicillin allergy
Cidal, excreted through kidneys, imipenem not given with cilastatin
empiric treatment for serious/resistant infection

21
Q

Monobactam: aztreonam

A

IV
GN only (anaerobe and aerobe)
Cidal, excreted by kidney
used if allergy to other beta-lactam (pen, cephalosporin)

22
Q

Glycopeptide: vancomycin

A

bind terminal D-ala-D-ala of peptidoglycan and inhibit glycosyltransferase and transpeptidase
IV or PO
GP only (inc MRSA and anaerobies like C diff)
GN intrinsic resistance due to outer memb, vanA plasmid change d-ala to d-lac (VRE and VRSA), inc cell wall turnover (VISA)
red man syndrome from infusion, ototoxicity, nephrotoxicity
cidal, excreted by kidney, oral doesnt cross GI, fair tissue penetration (poor resp; into meninges when inflamed)
inferior to beta-lactams; GP bac infection resistant to beta-lactams (MRSA), allergies to pen/cephalosporins; empiric treatment of serious GP infection; C diff

23
Q

Ccyclic lipopeptides

A

Lipophilic tail insert into membrane, membrane depol, cessation of vital cell processes, death (cidal but no lysis)
IV
GP (MRSA, VRE, anaerobes)
GN inherent resistance
GI, rash, headache; elevations of CPK and rhabdomyolysis; not given with statins
-cidal, conc-dep killing; doesnt cross BBB; excreted by kidneys
inhibited by pulmonary surfactant so not used for pneumonia
complicated skin/soft tissue infection, bacteremia, endocarditis

24
Q

Polymyxin: polymyxin B, colistin (E)

A

amphipathic mols bind LPS and disrupt outer membrane
Mostly topical (also IV, aerolized)
GN bacilli only
IV use decline due to nephrotoxcitiy, neurotoxicity, poor efficacy/availability
ICU for resisant GN infections (acinetobacter and pseudomonas)
inhaled formulation for GN infection in lung (resistant GN pneumonia)

25
Q

Bacitracin

A

inhibit synthesis of cell wall, LPS, capsule
topical (OTC ointment)
GP only (GAS- staph aureus, strep pyogenes)
superficial skin infection

26
Q

Fosfomycin

A

No synthesis of acetyl muramic acid
oral (powder)
GP and GN
resistance devlops rapidly due to mut in transporter used to import drug
single dose therapy bc high/prolonged conc in UT
only for UTIs

27
Q

Aminoglycosides: gentamicin, amikacin

A

bind 30S so misread/terminate DNA
IV
GN (pseudomonas), GP if used with beta lactams, mycobac, francisella tularensis, yersina pestis
Chrom (dec uptake of drug or enzyme that inactivate drug), lower rec affinity for drug (MTB)
ototoxicity (cochlear, vestibular damage), nephrotoxicity, neuromuscular block (not in MG patients)
high conc in renal cortex and inner ear, inactivated by acid (not for pneumonia), don’t penetrate liquid (not for abscess), cross placental barrier
UTIs in hospital, tularemia and plague, TB, GN infection (bacteremia, sepsis), GP infection (staph auerues or enterococcal endocarditis)

28
Q

Tetracycline: doxycycline, tetracycline, minocycline

A

reversibly bind 30S and block access to tRNA
IV or PO
GN (no pseudomonas), GP (CA-MRSA), atypicals (chlamydia, mycoplasma), spirochetes (borelia, leptospira)
resistance is widespread so limit use (plasmids encode prots for efflux and RPPs)
discoloration and hypoplasia of teeth, stunted growth, photosensitivity, hypersensitivity, lupu-like rxn, rarely hepatoxic/vestibular effects
static, incomplete abs with oral, dec abs with dairy/calcium carbonate, bind tissues undergoing calcifcation (bone, teeth), cross placenta (not given in kids/pregnant owmen)
Bronchitis (CA-pne), chlamydia, lyme disease, leptospirosis, ricketsial infection, erhlichiosis, doxy for malaria prophylaxis and mino for acne

29
Q

Glycyclines: tigecycline

A

semi-synthetic derivative of tetracycline
IV
GN (not pseudomona, proteus, morganella, providencia), GP (inc MRSA, VRE), most anaerobes
enhanced protection against resistant compared to tetracycline
complicated skin/soft tissue infection
complicated intra-abdominal infection
CA-pneumonia (inc mortality risk)

30
Q

macrolides: azithromycin, erythromycin, clarithromycin

A

bind 50s and block txn
IV (clari is PO)
GN (no pseudo), GP, some GN anaerobes (prevotella, prophyromonas), atypicals
efflux pumps, target site alterations (erm), dec cell wall permeability (intrinsic resistant of enterobacteriaceae, pseudmonas, acinetobacter), enzymatic drug interaction
epigastric distress, prolong QT, hypkalemia, hypomagnesemia, bradycardia/arrhythmia
widely distirbuted in tissue except CSF, metabolzied by cyp450
azi: CA-pneumonia/bronchitis, atypical pneumonia, chlamydia, travelers diarrhea, prophylaxic myocbac avium in HIV patient
ery: drug motility
clari: H pylori and mycobacterium avium

31
Q

Lincosamides: clindamycin

A

bind 50S and block txn
IV or PO
GP (inc MRA), oral anaerobes (above dia; like bacteriodes fragilis), parasites (malaria, toxoplasmosis, babesia
inducible clindamycin resistance by erm gene
c diff, hepatotoxicity, agranulocytosis
good penetration of most tissues except CNS
CA aspiration pneumonia due to oral anaerobes, oral/ENT infection, human bite wounds, skin/soft tissue infection from CA-MRSA, TSS from GAS (im combo)

32
Q

oxazolidinones: linezolid, tedizolid

A

bind 50s and prevent formation of 70s initiation complex/inhibit translocation
tedizolid also target site interaction with peptidyl trnasferase
IV or PO
GP (inc MRSA and VRE); mycobacteria
resistance is uncommon (spont mut at drug target site, plasmid cfr)
bone marrow suppression (thrombocytopenia) with prolonged use, inhibit monoamine oxidase when givven with SSRIs (serotonin syndrome); lactic acidosis
100% bioavailability
VRE infections (not VRE endocarditis), nosocomial pneumonia due ot MRS, ocmplicated skin/soft tissue infection from GP (tedizolids only use)

33
Q

Mupirocin

A

Bind reversibly to isoleucyl tRNA synthetase so arrest prot and RNA synth (also prevent DNA synth and inhibit cell wall prod)
topical (poyethylene glycol water miscible ointment)
GP only (not enterococci)
MRSA may display low/high levels of resistance (mut in gene, plasmid resp)
propylene glycol base may irrate mucous memb/broken skin
uncomplicated skin and soft tissue infections by GP (impetigo, folliculitis), MRSA declonization of anterior nares, prophylaxis for cather-related infection

34
Q

DNA synthesis inhibitor: imidazole (metrionidazole, tinidazole)

A

enter by diffusion and produce free radicals
IV or PO
GN anaerobes (bacteroides fragilis, c diff (below dia)), protozoa (trichomonas, amoeba, giardia)
metallic taste and huge pulls; HA, vertigo, confusion, psychosis; vomiting and flushing when taken with alcohol
anaerobic infections below dia like intra-abdominal infections/abscess and C diff
trichomonas, bac vaginosis
aemeobiasis, giardiasis
bac overgrowth syndromes
crohns fistulae

Antimicrobials (1 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions